Shandong Keyuan Pharmaceutical Co (SZSE:301281) Cash Flow for Dividends: ¥-1.2 Mil (TTM As of Mar. 2026)


SZSE:301281 Shandong Keyuan Pharmaceutical Co Ltd SZSE:301281
67 GF Score
Price ¥46.62
GF Value ¥30.42
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Shandong Keyuan Pharmaceutical Co Cash Flow for Dividends?

Shandong Keyuan Pharmaceutical Co SZSE:301281 -7.54% 67 Cash Flow for Dividends is ¥-1.2 Mil as of Mar. 2026. GuruFocus rates SZSE:301281 with a GF Score™ of 67/100 and a GF Value™ of ¥30.42 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Shandong Keyuan Pharmaceutical Co's cash flow for dividends for the three months ended in Mar. 2026 was ¥-1.2 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was ¥-1.2 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Shandong Keyuan Pharmaceutical Co's quarterly payment of dividends stayed the same from Sep. 2025 (¥0.0 Mil) to Dec. 2025 (¥0.0 Mil) but then increased from Dec. 2025 (¥0.0 Mil) to Mar. 2026 (¥-1.2 Mil).

Shandong Keyuan Pharmaceutical Co's annual payment of dividends increased from Dec. 2023 (¥-30.9 Mil) to Dec. 2024 (¥-32.6 Mil) but then declined from Dec. 2024 (¥-32.6 Mil) to Dec. 2025 (¥-24.8 Mil).

Shandong Keyuan Pharmaceutical Co Cash Flow for Dividends Related Terms

Shandong Keyuan Pharmaceutical Co Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Shandong Keyuan Pharmaceutical Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Keyuan Pharmaceutical Co Cash Flow for Dividends Chart

Shandong Keyuan Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -30.94 -32.56 -24.82

Shandong Keyuan Pharmaceutical Co Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -1.16
SZSE:301281
67GF Score
Shandong Keyuan Pharmaceutical Co Ltd SZSE:301281
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Keyuan Pharmaceutical Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-1.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ¥-1.2 Mil mean?
Shandong Keyuan Pharmaceutical Co (SZSE:301281) has a Cash Flow for Dividends of ¥-1.2 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Shandong Keyuan Pharmaceutical Co and its competitors.
Is Shandong Keyuan Pharmaceutical Co's Cash Flow for Dividends too high?
Shandong Keyuan Pharmaceutical Co's current Cash Flow for Dividends is ¥-1.2 Mil. Overall, Shandong Keyuan Pharmaceutical Co has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Keyuan Pharmaceutical Co's Cash Flow for Dividends compare to LLY and JNJ?
Shandong Keyuan Pharmaceutical Co's Cash Flow for Dividends of ¥-1.2 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Shandong Keyuan Pharmaceutical Co and its competitors. Shandong Keyuan Pharmaceutical Co's current Cash Flow for Dividends is ¥-1.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Keyuan Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Keyuan Pharmaceutical Co (SZSE:301281) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥30.42, compared to a current price of ¥46.62 — trading 53.3% above its estimated fair value. The current Cash Flow for Dividends is ¥-1.2 Mil. Shandong Keyuan Pharmaceutical Co's overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Shandong Keyuan Pharmaceutical Co (SZSE:301281), the current Cash Flow for Dividends is ¥-1.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Keyuan Pharmaceutical Co (SZSE:301281) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Keyuan Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥46.62 is trading 53.3% above its estimated GF Value™ of ¥30.42. GuruFocus considers Shandong Keyuan Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for SZSE:301281:

  • Cash Flow for Dividends: ¥-1.2 Mil
  • GF Value™: ¥30.42 vs. price of ¥46.62 (53.3% above fair value)
  • GF Score™: 67/100 with 7 warning signs

No single metric tells the full story. See the SZSE:301281 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shandong Keyuan Pharmaceutical Co Business Description

Address Keyuan Street, Shandong Shanghe Economic Development Zone, Shandong Province, Jinan, CHN, 251601
Shandong Keyuan Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of chemical raw materials and their preparations.
67GF Score

Get the complete analysis for SZSE:301281

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥46.62
Price
¥30.42
GF Value